Identification of serologic biomarkers for predicting microvascular invasion in hepatocellular carcinoma

Microvascular invasion (MVI) of hepatocellular carcinoma (HCC) is a major risk factor for early recurrence and poor survival after curative surgical therapies. However, MVI can only be diagnosed by pathological examination following resection. The aim of this study is to identify serologic biomarker...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Yu, Yuan-Quan, Wang, Liang, Jin, Yun, Zhou, Jia-Le, Geng, Yan-Hua, Jin, Xing, Zhang, Xiao-Xiao, Yang, Jun-Jie, Qian, Cheng-Ming, Zhou, Dong-Er, Liu, Da-Ren, Peng, Shu-You, Luo, Yan, Zheng, Lei, Li, Jiang-Tao
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941320/
https://ncbi.nlm.nih.gov/pubmed/26918350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7649
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars